Lineage Cell Therapeutics (LCTX) Share-based Compensation (2010 - 2026)
Lineage Cell Therapeutics' Share-based Compensation came in at $1.6 million for Q2 2026, up 29.3% from $1.24 million a year earlier and up 36.6% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Share-based Compensation (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Lineage Cell Therapeutics reported Share-based Compensation of $5.07 million, down 0.6% year-over-year; for FY2025, it was $4.75 million, down 6.4% from FY2024.
- Share-based Compensation carries a five-year compound annual growth rate of 16.4% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $5.08 million in FY2024 (+9.4%), $4.64 million in FY2023 (+8.2%), $4.29 million in FY2022 (+21.8%) and $3.52 million in FY2021 (+58.0%).
- The Q2 2026 figure represents the highest quarterly Share-based Compensation since Q4 2018.
- Year-over-year, Share-based Compensation increased in four of the last eight quarters, with growth averaging 3.8%.
- The fastest year-over-year change in Share-based Compensation over five years came in Q3 2021 (growth of 128.3%), and the weakest in Q4 2025 (a decline of 16.5%).
- Business Quant data shows LCTX's Share-based Compensation at $1.17 million (Q1 2026), $1.1 million (Q4 2025) and $1.2 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Lineage Cell Therapeutics | 245.32 Mn | 43.73 Mn | - | 1.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.60 Mn |
| Mar 31, 2026 | 1.17 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 1.20 Mn |
| Jun 30, 2025 | 1.24 Mn |
| Mar 31, 2025 | 1.22 Mn |
| Dec 31, 2024 | 1.32 Mn |
| Sep 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 1.27 Mn |
| Mar 31, 2024 | 1.16 Mn |
| Dec 31, 2023 | 1.06 Mn |
| Sep 30, 2023 | 1.27 Mn |
| Jun 30, 2023 | 1.28 Mn |
| Mar 31, 2023 | 1.03 Mn |
| Dec 31, 2022 | 959,000.00 |
| Sep 30, 2022 | 987,000.00 |
| Jun 30, 2022 | 1.24 Mn |
| Mar 31, 2022 | 1.11 Mn |
| Dec 31, 2021 | 918,000.00 |
| Sep 30, 2021 | 1.14 Mn |
API Access
Lineage Cell Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();